282 related articles for article (PubMed ID: 16750447)
1. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
Kaliner MA
Clin Ther; 2006 Mar; 28(3):319-31. PubMed ID: 16750447
[TBL] [Abstract][Full Text] [Related]
2. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
Szefler S; Rohatagi S; Williams J; Lloyd M; Kundu S; Banerji D
Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
Richter K; Kanniess F; Biberger C; Nave R; Magnussen H
J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
[TBL] [Abstract][Full Text] [Related]
4. Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate.
Agertoft L; Pedersen S
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e199-205. PubMed ID: 19320851
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids.
Bernstein DI; Allen DB
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877
[TBL] [Abstract][Full Text] [Related]
6. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
Lipworth BJ; Kaliner MA; LaForce CF; Baker JW; Kaiser HB; Amin D; Kundu S; Williams JE; Engelstaetter R; Banerji DD
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
Xu J; Nave R; Lahu G; Derom E; Derendorf H
J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
[TBL] [Abstract][Full Text] [Related]
8. [Ciclesonide -- a new inhaled corticosteroid].
Ukena D
Pneumologie; 2005 Oct; 59(10):689-95. PubMed ID: 16222581
[TBL] [Abstract][Full Text] [Related]
9. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
Dyer MJ; Halpin DM; Stein K
BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices.
Nave R; Fisher R; McCracken N
Respir Res; 2007 Sep; 8(1):65. PubMed ID: 17883839
[TBL] [Abstract][Full Text] [Related]
12. The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide.
Meltzer EO; Derendorf H
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):149-57. PubMed ID: 16937743
[TBL] [Abstract][Full Text] [Related]
13. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
[TBL] [Abstract][Full Text] [Related]
14. Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review.
Wlodarczyk JH; Gibson PG; Caeser M
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):23-30. PubMed ID: 18254478
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
Zöllner EW; Lombard CJ; Galal U; Hough FS; Irusen EM; Weinberg E
Pediatrics; 2012 Dec; 130(6):e1512-9. PubMed ID: 23147980
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma.
Pedersen S; Garcia Garcia ML; Manjra A; Theron I; Engelstätter R
Pediatr Pulmonol; 2006 Oct; 41(10):954-61. PubMed ID: 16868976
[TBL] [Abstract][Full Text] [Related]
17. Ciclesonide and the treatment of asthma.
Korenblat PE
Expert Opin Pharmacother; 2010 Feb; 11(3):463-79. PubMed ID: 20102309
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.
Derendorf H
J Clin Pharmacol; 2007 Jun; 47(6):782-9. PubMed ID: 17412829
[TBL] [Abstract][Full Text] [Related]
19. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
Derom E; Louis R; Tiesler C; Engelstätter R; Kaufman JM; Joos GF
Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
[TBL] [Abstract][Full Text] [Related]
20. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
Nave R; Zech K; Bethke TD
Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]